WallStreetZenWallStreetZen

NASDAQ: KPRX
Kiora Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

KPRX past revenue growth

How has KPRX's revenue growth performed historically?
Company
N/A
Industry
145.73%
Market
17.2%
KPRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KPRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

KPRX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$13.0M
Current Profit Margin
0%

KPRX Return on Equity

Current Company
-137.3%
Current Industry
-63.5%
Current Market
188%
KPRX's Return on Equity (-137.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when KPRX announces earnings.

KPRX Return on Assets

Current Company
-79%
Current Industry
2.9%
KPRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

KPRX Return on Capital Employed

Current Company
-102.77%
Current Industry
19.5%
KPRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KPRX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
KPRX$0.00-$12.35M-$13.04M-100.00%N/A
ATHE$0.00N/A-$8.03MN/AN/A
SNTI$2.56M-$65.63M-$71.06M+152.19%N/A
IKT$260.50k-$18.85M-$19.03M-42.21%N/A
NNVC$0.00-$8.55M-$9.36MN/AN/A
View Top Biotech Stocks

KPRX earnings dates

Next earnings date
May 7, 2024

Kiora Pharmaceuticals Earnings & Revenue FAQ

What were KPRX's earnings last quarter?

On Invalid Date, Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q4 2023 earnings per share (EPS) of $0.04, up 98.86% year over year. Total Kiora Pharmaceuticals earnings for the quarter were -$2.27 million. In the same quarter last year, Kiora Pharmaceuticals's earnings per share (EPS) was $3.51.

If you're new to stock investing, here's how to buy Kiora Pharmaceuticals stock.

What was KPRX's earnings growth in the past year?

As of Q2 2024, Kiora Pharmaceuticals's earnings has grown year over year. Kiora Pharmaceuticals's earnings in the past year totalled -$13.04 million.

What is KPRX's earnings date?

Kiora Pharmaceuticals's earnings date is Invalid Date. Add KPRX to your watchlist to be reminded of KPRX's next earnings announcement.

What was KPRX's revenue last quarter?

On Invalid Date, Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Kiora Pharmaceuticals's revenue was $0.00.

What was KPRX's revenue growth in the past year?

As of Q2 2024, Kiora Pharmaceuticals's revenue has grown null year over year. Kiora Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.